Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariko Sawa

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Journal of Veterinary Medical Science|December 13, 2016
Degenerative myelopathy in the Collie breed: a retrospective immunohistochemical analysis of superoxide dismutase 1 in an affected Rough Collie, and a molecular epidemiological survey of the SOD1: c.118G>A mutation in JapanMoeko Kohyama, Masato Kitagawa, Hiroaki Kamishina, et al.
Annals of Neurology|April 12, 2023
Retromer Proteins Reduced in Down Syndrome and the Dp16 Model: Impact of APP Dose and Preclinical Studies of a γ-Secretase ModulatorXu-Qiao Chen, Mariko Sawa, Ann Becker, et al.
Developmental Cell|May 21, 2019
Multi-level Modulation of Light Signaling by GIGANTEA Regulates Both the Output and Pace of the Circadian ClockMaria A Nohales, Wanlu Liu, Tomas Duffy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 10, 2021
Impact of increased APP gene dose in Down syndrome and the Dp16 mouse modelMariko Sawa, Cassia Overk, Ann Becker, et al.
The Journal of Clinical Investigation|April 12, 2016
Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegenerationWei Xu, April M Weissmiller, Joseph A White, et al.
Science (New York, N.Y.)|July 17, 2012
Identification of small molecule activators of cryptochromeTsuyoshi Hirota, Jae Wook Lee, Peter C St John, et al.
The Journal of Experimental Medicine|March 2, 2021
Preclinical validation of a potent γ-secretase modulator for Alzheimer's disease preventionKevin D Rynearson, Moorthi Ponnusamy, Olga Prikhodko, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Journal of Veterinary Medical Science|December 13, 2016
Degenerative myelopathy in the Collie breed: a retrospective immunohistochemical analysis of superoxide dismutase 1 in an affected Rough Collie, and a molecular epidemiological survey of the SOD1: c.118G>A mutation in JapanMoeko Kohyama, Masato Kitagawa, Hiroaki Kamishina, et al.
Annals of Neurology|April 12, 2023
Retromer Proteins Reduced in Down Syndrome and the Dp16 Model: Impact of APP Dose and Preclinical Studies of a γ-Secretase ModulatorXu-Qiao Chen, Mariko Sawa, Ann Becker, et al.
Developmental Cell|May 21, 2019
Multi-level Modulation of Light Signaling by GIGANTEA Regulates Both the Output and Pace of the Circadian ClockMaria A Nohales, Wanlu Liu, Tomas Duffy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 10, 2021
Impact of increased APP gene dose in Down syndrome and the Dp16 mouse modelMariko Sawa, Cassia Overk, Ann Becker, et al.
The Journal of Clinical Investigation|April 12, 2016
Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegenerationWei Xu, April M Weissmiller, Joseph A White, et al.
Science (New York, N.Y.)|July 17, 2012
Identification of small molecule activators of cryptochromeTsuyoshi Hirota, Jae Wook Lee, Peter C St John, et al.
The Journal of Experimental Medicine|March 2, 2021
Preclinical validation of a potent γ-secretase modulator for Alzheimer's disease preventionKevin D Rynearson, Moorthi Ponnusamy, Olga Prikhodko, et al.
Pageof 3